Psoriasis systematically alters the inflammatory biochemistry of the blood
the verdict
SUPPORTED
the evidence backs this
confidence 84/100
Clinical studies consistently show that psoriasis is associated with systemic changes in blood inflammatory biochemistry, including elevated C-reactive protein, white blood counts, and specific biomarkers like FABP5.
Evidence for · 3
Impact of Elevated Serum Uric Acid Levels on Systemic Inflammation in Patients With Psoriasis
2016 · cited by 21
This study found that patients with psoriasis exhibit elevated systemic inflammation markers, such as CRP, white blood cell count, and neutrophil to lymphocyte ratio, compared to healthy controls.
See more details
More for · 2
Serum Fatty Acid Binding Protein 5 (FABP5) as a Potential Biomarker of Inflammation in Psoriasis.
2020 · cited by 1
This study demonstrated that serum FABP5 levels are significantly higher in psoriatic patients and correlate with basic inflammation indices like CRP, supporting systemic biochemical alterations.
Serum Fatty Acid Binding protein 5 (FABP5) as a Potential Biomarker of Inflammation in Psoriasis.
2020 · cited by 0
This duplicate study similarly reported elevated serum FABP5 and its positive correlation with inflammatory markers in patients with psoriasis.